drugset / Trial / NCT04306692
Myo-inositol Versus Clomiphene Citrate in PCOS
Phase 4
Terminated
12 enrolled
University Hospital, Ghent
AZ Jan Palfijn Gent · collabGedeon Richter Ltd. · collabOur Lady of Lourdes Hospital Waregem · collabUniversity Hospital, Antwerp · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
Specific aim: To compare inositol and the golden standard first line treatment of ovulation induction, namely clomiphene citrate.
Timeline
- Start
- 2020-07-02
- Primary completion
- 2021-04-20
- Completion
- 2022-01-31
Outcome
Outcome not reported
Stopped: “clomiphene citrate is no longer being considered as standard treatment for polycystic ovary syndrome”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Clomiphene Citrate | Other / unclassified | 33.9 mg | Oral |
| Subject | Myo-inositol | Small molecule | 4000 mg | Oral |